What one share of Rocket Pharmaceuticals holds
We are a fully integrated, late-stage biotechnology company focused on the development, manufacturing, and potential commercialization of genetic therapies for rare and often fatal diseases with high unmet medical need.
Rocket Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.00 |
|---|---|
| Profit | −$0.15 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$1.51 |
| Cash and investments | $2.05 |
| Book value | $3.37 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2014 | — | −$54.10 | — | — | — | −$202.17 |
| 2015 | — | −$14.88 | $0.09 | −$3.89 | — | $2.35 |
| 2016 | $0.00 | −$1.11 | $0.05 | −$0.85 | — | $1.24 |
| 2017 | $0.00 | −$2.88 | $0.11 | −$2.46 | — | $2.28 |
| 2018 | $0.00 | −$1.89 | $0.04 | −$1.40 | — | $4.30 |
| 2019 | $0.00 | −$1.58 | $0.47 | −$1.79 | — | $5.61 |
| 2020 | $0.00 | −$2.52 | $0.37 | −$1.72 | — | $8.25 |
| 2021 | $0.00 | −$2.67 | $0.12 | −$2.04 | — | $7.05 |
| 2022 | $0.00 | −$3.26 | $0.12 | −$2.74 | — | $6.19 |
| 2023 | $0.00 | −$2.92 | $0.20 | −$2.52 | — | $5.46 |
| 2024 | $0.00 | −$2.73 | $0.06 | −$2.27 | — | $4.35 |
| 2025 | $0.00 | −$2.01 | $0.00 | −$1.71 | — | $2.56 |
Common questions about Rocket Pharmaceuticals
How much does one share of Rocket Pharmaceuticals earn?
Over the last 12 months, Rocket Pharmaceuticals lost $0.15 for each share.
Does Rocket Pharmaceuticals pay a dividend?
Rocket Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Rocket Pharmaceuticals’s book value per share?
Rocket Pharmaceuticals’s book value is $3.37 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Rocket Pharmaceuticals have?
Each share of Rocket Pharmaceuticals has $2.05 of cash and investments, as of June 30, 2026.
What is Rocket Pharmaceuticals’s free cash flow per share?
−$1.51 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Rocket Pharmaceuticals bought back shares?
Rocket Pharmaceuticals’s share count rose about 43474% from 2014 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.